Home>Media>News Room

News Room


TCG Lifesciences congratulates Curadev for its recent research collaboration and licensing agreement to develop cancer immunotherapeutic candidate

Kolkata, India - June 8, 2015 - TCG Lifesciences Limited (formerly "Chembiotek Research International"), a leading contract research services company in the area of early drug discovery and development congratulates Curadev Pharma Private Limited for its research collaboration and exclusive license agreement for the development and commercialization of IDO1 and TDO inhibitors. TCG Lifesciences provided chemistry synthesis of molecules and preliminary scale up of the lead molecule for Curadev. More>>


Debiopharm Group™ and TCG Lifesciences Ltd. announce successful completion of first phase of research collaboration on discovery of novel antibiotics
Lausanne, Switzerland and Kolkata, India – June 24, 2014 - Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs, including anti-bacterial, oncology as well as companion diagnostics, and TCG Lifesciences Limited (TCGLS) a leading contract research services company in the area of early drug discovery and development, today announced that they have reached the first research milestone and consequently enter into lead optimization phase for innovative antibiotics targeting drug-resistant bacteria for community and hospital-acquired infections. More>>


Axcellerate Pharma, New Jersey aims to become a market leader in high-value, niche offerings to the US life sciences industry
Kolkata, India - November 20, 2013 - Axcellerate Pharma establishes CMO/CRO and API manufacturing facility in New Jersey, US. Focus will be small molecule and biologics PR&D, innovative technology platforms, filling vial and bag operations, peptide synthesis, oligonucleotide production and related areas. More>>


Debiopharm Group™ and TCG Lifesciences Ltd. enter into an exclusive Research agreement to develop a novel class of antibiotics, a new strategic therapeutic area for Debiopharm
Lausanne, Switzerland and Kolkata, India - September 9th, 2013 - Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs, including oncology as well as companion diagnostics, and TCG Lifesciences Limited (TCGLS) a leading contract research services company in the area of early drug discovery and development, today announced the signature of an exclusive discovery collaboration to develop innovative antibiotics targeting drugresistant bacteria for community hospital-acquired infections.More>>


Integrating R&D and cGMP kilo-scale synthesis for new therapeutic products
November/December 2012 - TCG Lifesciences is a contract research services company headquartered in India and with a worldwide presence offering research support ranging from specific solutions to integrated discovery projects across multiple therapeutic areas. More>>


What to Consider When Looking for a CRO
November 15, 2012 - Most contract research organizations (CROs) offer a wide variety of services ranging from preclinical studies and consultancy/advice to full clinical trials and regulatory support. More>>


The jury members cast their vote
New Delhi, India - November 08, 2012 - A eleven member jury comprising of experts from academia, industry and finance met at the International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi on October 4, 2012 to select the achievers in bioscience area for BioSpectrum Awards 2012. More>>


"We provide services to 14 of the top 20 pharma companies"
Kolkata, India - April 10, 2012 - Innovative partnership is a key element for CROs to sustain the rapid changes in the pharma industry. TCG Life Sciences (TCGLS), a leading contract research services, clinical research, and laboratory informatics company with operations in India, Europe, Japan, Australia and the US, offers a unique mode, which it has built on its strengths and forged strategic partnerships that has helped it essay the role of a partner rather than just a service provider. More>>


TCG Lifesciences Announces Nomination of Pre-clinical Development Candidate
Kolkata, India - February 16, 2012 - TCG Lifesciences Limited ("TCGLS") announced today the nomination of a pre-clinical development candidate ("Candidate") under a R&D collaboration entered into in 2009 with Pfizer Inc. ("Pfizer"). More>>


TCG Lifesciences completes key milestones on delivery of pre-clinical drug candidates to Endo Pharmaceuticals
Kolkata, India - January 30, 2012 - TCG Lifesciences Limited (TCGLS) announced the achievement of two distinct milestones in their ongoing drug discovery partnership with Endo Pharmaceuticals. More>>


Contract research and bioinformatics - a global perspective
November/December 2011 - TCG Lifesciences Limited is a provider of contract research services and informatics with a focus on preclinical outsourcing and drug discovery operations in India, USA, Europe, Japan and Australia. More>>


TCG Lifesciences collaborates with JSW Lifesciences in the area of CNS
Kolkata, India - November 16, 2011 - TCG Lifesciences Limited (TCGLS) has announced that it has entered into a strategic agreement with JSW Lifesciences (JSW). More>>


TCG Lifesciences Donates for Japan Earthquake and Tsunami
New Delhi, India - May 3, 2011 - The 'Japan Relief Fundraising Campaign' initiative by TCG Lifesciences last month saw the TCGLS community earnestly coming forward and participating in the campaign. More>>


TCG Lifesciences Expands Pharmaceutical, Biotechnology Research Initiatives with CAS' SciFinder®
Kolkata, India - April 4, 2011 - the world's authority for chemical information, announced today that TCG Lifesciences Limited, a leading contract research services and informatics company based in India, has signed a three-year contract to provide its scientists and researchers with unlimited access to SciFinder. More>>


TCG Lifesciences and CarnaBio enter into Strategic Alliance for ‘Kinase’ Based Drug Discovery Services
Kolkata, India - October 12, 2010 - TCG Lifesciences, Ltd (“TCGLS”) of India and Carna Biosciences, Inc (“CarnaBio”) of Japan have entered into a strategic alliance to collaborate and provide jointly, high end drug discovery services focusing on kinase targets, to the global pharma and biotech companies. More>>

 

View Archives>>

Contact Us
Corporate Affairs and Communications:
media@tcgls.com